Clinical Trials Directory

Trials / Conditions / Leishmaniasis, Cutaneous

Leishmaniasis, Cutaneous

25 registered clinical trials studyying Leishmaniasis, Cutaneous — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingArnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.
NCT06822478
Universidad de AntioquiaPhase 3
Not Yet RecruitingAntimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutane
NCT06695143
Institute of Tropical Medicine, BelgiumPhase 3
RecruitingLEISH-PED: Study on Leishmaniasis in Children
NCT07504757
Meyer Children's Hospital IRCCS—
Active Not RecruitingArnica Tincture Fot the Treatment of Cutaneous Leishmaniasis
NCT05094908
Universidad de AntioquiaPhase 1
UnknownIntralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Le
NCT05708625
Zagazig UniversityPhase 3
CompletedEnhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy
NCT06917040
The Mentor InitiativePhase 3
WithdrawnEvaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasi
NCT04072874
Universidad de AntioquiaPhase 1 / Phase 2
CompletedInvestigation of an Outbreak Situation of Cutaneous Leishmaniasis Among Military Personnel in French Guiana (C
NCT04888130
Centre Hospitalier de Cayenne—
CompletedA Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL
NCT03969134
University of YorkPhase 2
CompletedA Clinical Study to Develop an Uninfected Sand Fly Biting Protocol
NCT03999970
University of YorkN/A
UnknownEvaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru
NCT03762070
Naval Medical Research Center—
CompletedASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPO
NCT03303898
Centre Hospitalier Universitaire de NiceN/A
CompletedTopical Paromomycin for Cutaneous Leishmaniasis in Bolivia
NCT03096457
Fundacion Nacional de DermatologiaPhase 2 / Phase 3
CompletedA Study of a New Leishmania Vaccine Candidate ChAd63-KH
NCT02894008
University of YorkPhase 2
CompletedMiltefosine Plus IL Pentamidine for Bolivian CL
NCT03445897
Jonathan BermanPhase 2
CompletedFourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis
NCT03294161
Hospital Universitário Professor Edgard SantosPhase 2
TerminatedSafety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis
NCT01140191
U.S. Army Medical Research and Development CommandPhase 2
CompletedDevelopment of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis
NCT04841239
Jinnah Sindh Medical UniversityN/A
CompletedPharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromo
NCT01083576
U.S. Army Medical Research and Development CommandPhase 2
CompletedSafety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous L
NCT01032382
U.S. Army Medical Research and Development CommandPhase 2
CompletedTreatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
NCT00480883
Combined Military Hospital, PakistanN/A
CompletedAntihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis
NCT00469495
Hospital Universitário Professor Edgard SantosN/A
CompletedStudy to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
NCT00111553
Access to Advanced Health Institute (AAHI)Phase 1
No Longer AvailableParomomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis
NCT01641796
U.S. Army Medical Research and Development Command—
No Longer AvailableCompassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
NCT00508963
University of California, San Francisco—